Clinicians order food allergy panels despite false-positive risk

A survey presented at the 2026 ACAAI meeting reveals that many clinicians continue to order broad food allergy panels despite knowing they frequently yield false-positive results. Experts warn that these unnecessary tests lead to dietary restrictions, increased costs, and patient stress.
Why it matters
This highlights a gap between clinical knowledge and practice, impacting healthcare efficiency and patient well-being.
Most clinicians who order broad serum IgE food allergy panels know the tests frequently return false-positive results, yet many continue to order them for indications experts do not support, according to survey data presented at the 2026 American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting in Phoenix, Arizona.¹ Of 43 respondents, 85% recognized that the panels have high false-positive rates, and 21% said they had ordered one because a patient or family asked for it.²
"Most of the clinicians we surveyed already knew these tests could lead to false positive results, but many still ordered them despite current guidelines advising against their use," said senior author Katelyn Wong, MD, an allergist-immunologist in New Haven, Connecticut, and an ACAAI member.¹ "False positive results can lead families to cut out foods that were never actually unsafe, cause unnecessary stress, and add extra costs."¹
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in